Global Vaccine Adjuvants Market Research Report, Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

  • ID: 4496881
  • Report
  • Region: Global
  • 190 Pages
  • Occams Business Research and Consulting
1 of 5

FEATURED COMPANIES

  • Agenus, Inc.
  • Brenntag Biosector
  • CSL Limited
  • Novavax, Inc.
  • SEPPIC
  • MORE

Adjuvants are the immunological agents deployed in vaccines for enhancing body’s immune response to the vaccine and its ability to induce protection against infection. The global vaccine adjuvants market is growing at a CAGR of 10.25% during forecast period 2016-2023. Increasing use of adjuvants in vaccine, high prevalence of infectious diseases and zoonotic diseases, increasing government focus on immunization programs, increasing geriatric population and increasing R&D in vaccine adjuvants are driving the growth of the market. According to Centre for Disease Control and Prevention, zoonotic diseases prevalence is found to be common in U.S. and around 10,000 American population every year get infected from germs that are communicable through animals. Further, it is stated that every 6 out of 10 people are infected from known infectious disease spread by animals. Moreover, occurrence of these diseases are found in children’s above age 5 and in adults of 65 age and above along with people having weak immune system. At this scenario of increasing communicable and zoonotic diseases, demand for proper vaccines increases which in return increases the demand for deploying adjuvants for enhancing immune response of patient to the vaccine.

Increasing focus on immunization programs by governments has accelerated growth of market, For instance, U.S. National Adult Immunization Program targeting specifically adults for vaccination with a goal of strengthening immunization infrastructure for adults, to develop better access to vaccines for adults, and develop new technologies related to vaccination and adult vaccine innovation. Further, India’s Universal Immunization Program (U.I.P) is one of the world’s largest programs in terms of quantities of vaccines used in program, in terms of area covered by program, in number of benefited peoples and programs organized. Further, China National Immunization Program is a government program with a goal to eliminate and control vaccine preventable diseases.

Global market for vaccine adjuvants is expected to dominate by North America region during the forecast period due to high geriatric population and increased investment in healthcare sector. However, Asia-Pacific is expected to account for the fastest growth for forecast period due to the growing healthcare awareness and initiatives by government.

READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Agenus, Inc.
  • Brenntag Biosector
  • CSL Limited
  • Novavax, Inc.
  • SEPPIC
  • MORE

1. Introduction
1.1. Executive Summary
1.2. Estimation Methodology

2. Market Overview
2.1. Global Vaccine Adjuvants Market: Evolution & Transition
2.2. Market Definition & Scope
2.3. Industry Structure
2.4. Regulatory Framework
2.5. Total Market Analysis
2.5.1. Top 5 Findings
2.5.2. Top 5 Opportunity Markets
2.5.3. Top 5 Companies
2.5.4. Top 3 Competitive Strategies
2.6. Estimation Analysis
2.7. Strategic Analysis
2.7.1. Investment Vs. Adoption Model
2.7.2. 360 Degree Industry Analysis
2.7.3. Porters 5 Force Model
2.7.4. See-Saw Analysis
2.7.5. Consumer Analysis And Key Buying Criteria
2.8. Competitive Analysis
2.8.1. Key Strategies & Analysis
2.8.2. Market Share Analysis & Top Company Analysis
2.9. Strategic Recommendations & Key Conclusions
2.9.1. Investment Opportunities By Region
2.9.2. Opportunities In Emerging Applications
2.9.3. Investment Opportunity In Fastest Growing Segment

3. Market Determinants
3.1. Market Drivers
3.1.1. Increasing Use Of Adjuvants In Vaccine
3.1.2. High Prevalence Of Infectious And Zoonotic Diseases
3.1.3. Increase In Livestock And Instances Of Diseases
3.1.4. Increasing Government Focus On Immunization Programs
3.1.5. Increasing Geriatric Population
3.2. Market Restraints
3.2.1. High Cost Of Adjuvant Research
3.2.2. Stringent Regulatory Environment And Time-Consuming Approvals
3.3. Market Opportunities
3.3.1. Introduction Of Combination Adjuvants
3.4. Market Challenges
3.4.1. Identification Of Adjuvants

4. Market Segmentation
4.1. Global Vaccine Adjuvants Market By Product Type
4.1.1. Market Definition And Scope
4.1.2. Decision Support Database & Estimation Methodology
4.1.3. Comparative Analysis Across Market Segments
4.1.4. Opportunity Matrix
4.1.5. Market Segmentation
4.1.5.1. Global Particulate Adjuvants Market
4.1.5.1.1. Adoption Scenario & Market Determinants
4.1.5.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.1.3. Key Players & Key Products
4.1.5.1.4. Key Conclusions
4.1.5.2. Global Adjuvant Emulsions Market
4.1.5.2.1. Adoption Scenario & Market Determinants
4.1.5.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.2.3. Key Players & Key Products
4.1.5.2.4. Key Conclusions
4.1.5.3. Global Pathogen Components Market
4.1.5.3.1. Adoption Scenario & Market Determinants
4.1.5.3.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.3.3. Key Players & Key Products
4.1.5.3.4. Key Conclusions
4.1.5.4. Global Combination Adjuvants Market
4.1.5.4.1. Adoption Scenario & Market Determinants
4.1.5.4.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.4.3. Key Players & Key Products
4.1.5.4.4. Key Conclusions
4.1.5.5. Global Others Market
4.1.5.5.1. Adoption Scenario & Market Determinants
4.1.5.5.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.5.3. Key Players & Key Products
4.1.5.5.4. Key Conclusions
4.2. Global Vaccine Adjuvants Market By Route Of Administration
4.2.1. Market Definition And Scope
4.2.2. Decision Support Database & Estimation Methodology
4.2.3. Comparative Analysis Across Market Segments
4.2.4. Opportunity Matrix
4.2.5. Market Segmentation
4.2.5.1. Global Intramuscular Route Market
4.2.5.1.1. Application
4.2.5.1.2. Adoption Scenario & Market Determinants
4.2.5.1.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.1.4. Key Players & Key Products
4.2.5.1.5. Key Conclusions
4.2.5.2. Global Subcutaneous Route Market
4.2.5.2.1. Application
4.2.5.2.2. Adoption Scenario & Market Determinants
4.2.5.2.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.2.4. Key Players & Key Products
4.2.5.3. Global Intranasal Route Market
4.2.5.3.1. Application
4.2.5.3.2. Adoption Scenario & Market Determinants
4.2.5.3.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.3.4. Key Players & Key Products
4.2.5.4. Global Oral Route Market
4.2.5.4.1. Application
4.2.5.4.2. Adoption Scenario & Market Determinants
4.2.5.4.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.4.4. Key Players & Key Products
4.2.5.5. Global Intradermal Route Market
4.2.5.5.1. Application
4.2.5.5.2. Adoption Scenario & Market Determinants
4.2.5.5.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.5.4. Key Players & Key Products
4.2.5.6. Global Others Market
4.2.5.6.1. Application
4.2.5.6.2. Adoption Scenario & Market Determinants
4.2.5.6.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.6.4. Key Players & Key Products
4.3. Global Vaccine Adjuvants Market By Disease Type
4.3.1. Market Definition And Scope
4.3.2. Decision Support Database & Estimation Methodology
4.3.3. Comparative Analysis Across Market Segments
4.3.4.  Opportunity Matrix
4.3.5. Market Segmentation
4.3.5.1. Global Infectious Diseases Market
4.3.5.1.1. Application
4.3.5.1.2. Adoption Scenario & Market Determinants
4.3.5.1.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.1.4. Key Players & Key Products
4.3.5.1.5. Key Conclusions
4.3.5.2. Global Cancer Market
4.3.5.2.1. Application
4.3.5.2.2. Adoption Scenario & Market Determinants
4.3.5.2.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.2.4. Key Players & Key Products
4.3.5.2.5. Key Conclusions
4.3.5.3. Global Others Market
4.3.5.3.1. Application
4.3.5.3.2. Adoption Scenario & Market Determinants
4.3.5.3.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.3.4. Key Players & Key Products
4.3.5.3.5. Key Conclusions
4.4. Global Vaccine Adjuvants Market By Application Category
4.4.1. Market Definition And Scope
4.4.2. Decision Support Database & Estimation Methodology
4.4.3. Comparative Analysis Across Market Segments
4.4.4. Opportunity Matrix
4.4.5. Market Segmentation
4.4.5.1. Global Human Vaccine Adjuvants Market
4.4.5.1.1. Application
4.4.5.1.2. Adoption Scenario & Market Determinants
4.4.5.1.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.4.5.1.4. Key Players & Key Products
4.4.5.1.5. Key Conclusions
4.4.5.2. Global Veterinary Vaccine Adjuvants Market
4.4.5.2.1. Application
4.4.5.2.2. Adoption Scenario & Market Determinants
4.4.5.2.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.4.5.2.4. Key Players & Key Products
4.4.5.2.5. Key Conclusions
4.5. Global Vaccine Adjuvants Market By Application
4.5.1. Market Definition And Scope
4.5.2. Decision Support Database & Estimation Methodology
4.5.3. Comparative Analysis Across Market Segments
4.5.4. Opportunity Matrix
4.5.4.1.1. Market Segmentation
4.5.4.2. Global Research Application Market
4.5.4.2.1. Application
4.5.4.2.2. Adoption Scenario & Market Determinants
4.5.4.2.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.5.4.2.4. Key Players & Key Products
4.5.4.2.5. Key Conclusions
4.5.4.3. Global Commercial Application Market
4.5.4.3.1. Application
4.5.4.3.2. Adoption Scenario & Market Determinants
4.5.4.3.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.5.4.3.4. Key Players & Key Products
4.5.4.3.5. Key Conclusions

5. Competitive Landscape
5.1. Key Strategies
5.1.1. List Of Merger & Acquisition
5.1.2. List Of Joint Venture
5.1.3. List Of Product Launches
5.1.4. List Of Partnership
5.2. Top 10 Company Analysis

6. Geographical Analysis
6.1. Decision Support Database & Estimation Methodology
6.2. Comparative Analysis Across Market Segments
6.3. Opportunity Matrix
6.4. Global Vaccine Adjuvants Market By Region 2014-2023 ($ Million)
6.4.1. North America
6.4.1.1. Industry Analysis 2014-2023 ($ Million)
6.4.1.2. Top Country Analysis
6.4.1.2.1. U.S.
6.4.1.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.1.2. Key Players & Key Products
6.4.1.2.1.3. Key Conclusions
6.4.1.2.2. Canada
6.4.1.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.2.2. Key Players & Key Products
6.4.1.2.2.3. Key Conclusions
6.4.2. Europe
6.4.2.1. Industry Analysis 2014-2023 ($ Million)
6.4.2.2. Top Country Analysis
6.4.2.2.1. Uk
6.4.2.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.1.2. Key Players & Key Products
6.4.2.2.1.3. Key Conclusions
6.4.2.2.2. France
6.4.2.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.2.2. Key Players & Key Products
6.4.2.2.2.3. Key Conclusions
6.4.2.2.3. Germany
6.4.2.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.3.2. Key Players & Key Products
6.4.2.2.3.3. Key Conclusions
6.4.2.2.4. Russia
6.4.2.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.4.2. Key Players & Key Products
6.4.2.2.4.3. Key Conclusions
6.4.2.2.5. Rest Of Europe
6.4.2.2.5.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.5.2. Key Players & Key Products
6.4.2.2.5.3. Key Conclusions
6.4.3. Asia Pacific
6.4.3.1. Industry Analysis 2014-2023 ($ Million)
6.4.3.2. Top Country Analysis
6.4.3.2.1. China
6.4.3.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.1.2. Key Players & Key Products
6.4.3.2.1.3. Key Conclusions
6.4.3.2.2. India
6.4.3.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.2.2. Key Players & Key Products
6.4.3.2.2.3. Key Conclusions
6.4.3.2.3. Japan
6.4.3.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.3.2. Key Players & Key Products
6.4.3.2.3.3. Key Conclusions
6.4.3.2.4. Australia
6.4.3.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.4.2. Key Players & Key Products
6.4.3.2.4.3. Key Conclusions
6.4.3.2.5. Rest Of Asia Pacific
6.4.3.2.5.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.5.2. Key Players & Key Products
6.4.3.2.5.3. Key Conclusions
6.4.4. Row
6.4.4.1. Industry Analysis 2014-2023 ($ Million)
6.4.4.2. Top Country Analysis
6.4.4.2.1. Latin America
6.4.4.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.1.2. Key Players & Key Products
6.4.4.2.1.3. Key Conclusions
6.4.4.2.2. Middle East & Africa
6.4.4.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.2.2. Key Players & Key Products
6.4.4.2.2.3. Key Conclusions

7. Company Profiles
7.1. Adjuvatis (France)
7.1.1. Overview
7.1.2. Product Portfolio

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Agenus, Inc.
  • Brenntag Biosector
  • CSL Limited
  • Novavax, Inc.
  • SEPPIC
  • MORE

Global vaccine adjuvants market is expected to grow at a CAGR of 10.25% over the forecast period 2016-2023
Combination adjuvant is a new approach of enhancing immune system by drawing out multiple protective immune responses. Due to few limitations of adjuvants, single adjuvant is not capable of inducing entire protective immune response which is required in various vaccines. Thus, marketers are attracted towards potential of multiple adjuvants in a vaccine. Further, for synergic enhancement of immune system, correct selection of combination adjuvant is necessary. Thus, process of combination adjuvant is being utilized by vaccinologists for enhanced immune responses in specific vaccines. According to National Institute of Health (U.S.), The National Institutes of Allergy and Infectious Disease (U.S.) has granted $3.1million for research in molecular mechanism of combination vaccine adjuvants. This researches include improvement of current vaccines and developing vaccines for new diseases. Thus, combination adjuvant is offering new opportunities in global vaccine adjuvants market during forecast period.

Increasing livestock and disease outbreaks is fueling demand for vaccine adjuvants
The increasing livestock worldwide has contributed to the market growth as increasing livestock leads to the risk of disease which further increases deployment of vaccines for prevention of these diseases. Disease outbreaks are increasing globally and the utilization of more enhanced immune vaccines is rising. Rate of disease outbreaks due to infected animals are increasing and thus, the requirement to prevent diseases in livestock is also emerging. Adjuvants in vaccines increase immunity for long time period which makes vaccines more effective. Vaccine adjuvant consumption for humans as well as for animals rises due to increased infectious and zoonotic diseases (communicable through animals). According to United States Department of Agriculture, 2016, India’s cattle and buffalo population is expected to be 303.4 million head and production of beef is expected to increase by 2% of 303.4 and carabeef export to major countries such as Africa, South East Asia, Middle East is projected to increase to 2 million. According to Statistical Communique of People’s Republic of China, the overall production statistics shows there was 85.40 million tons meat production in which pork production was 52.99 million tons. Whereas, production of beef was 7.17 million ton which was increased by 2.4% from 2015, further production of mutton 4.59 million tons was increased by 4.2% in 2016 from 2015 and poultry production was 18.88 million tons in 2015 which is increased by 3.4% in 2016. Thus, increasing demand of livestock products has led to increased livestock. 

Increasing government focus on immunization programs: Growth driver
Various governments are developing and running programs for advancing the vaccination system areas, such as U.S. National Adult Immunization Program, which is targeting adults for vaccination with a goal of strengthening immunization infrastructure, develop better access to vaccines, develop new technologies related to vaccination for adults. According to India Ministry of Health and Family Welfare, India’s Universal Immunization Program (U.I.P) is one of the world’s largest programs in terms of quantities of vaccines used in program, in terms of area covered by program, in number of benefited people, number of immunization sessions organized. Further, China National Immunization Program is a government program with a goal to eliminate and control diseases which can be done by vaccines. Thus, increasing immunization programs by various countries globally have impacted market growth by accelerating demand for adjuvants in vaccines as the adjuvant helps to increase immunity of body. Disease outbreaks are increasing rapidly which gains focus of countries globally to step up in prevention of these diseases by increasing immune system of the people. For instance, according to World Health Organization report on Influenza 2018, the global burden of this disease is estimated to be around 3-5 million cases due to severe illness and around 290,000 to 650,000 deaths were occurred due to this disease. Thus, the rising zoonotic disease outbreaks is driving demand for vaccination for proper cure globally. Further, according to Center for Disease Control and Prevention, zoonotic disease outbreak is very common in U.S. and around 10,000 Americans get infected from harmful germs from animals every year. Moreover, scientists have accounted that around 6 out of 10 known infectious diseases are spread by animals, whereas 3 out of 4 emerging diseases in humans are spread by animals. This disease is majorly infected in children of above 5 year and adults above 65 and people with low immunity. Thus, the demand for utilizing adjuvants is increasing due to the outbreak of diseases which in turn accelerate the adoption of vaccination. The adoption of vaccination results in overall growth of vaccine adjuvants market.

Note: Product cover images may vary from those shown
5 of 5
  •  Brenntag Biosector
  •  CSL Limited
  •  SEPPIC
  •  Agenus, Inc.
  •  Novavax, Inc.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll